loading
Assembly Biosciences Inc stock is traded at $15.93, with a volume of 26,353. It is down -1.30% in the last 24 hours and down -12.66% over the past month. Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
See More
Previous Close:
$16.14
Open:
$16.29
24h Volume:
26,353
Relative Volume:
0.93
Market Cap:
$99.63M
Revenue:
-
Net Income/Loss:
$-61.23M
P/E Ratio:
-9.7731
EPS:
-1.63
Net Cash Flow:
$22.49M
1W Performance:
-2.92%
1M Performance:
-12.66%
6M Performance:
+9.64%
1Y Performance:
+84.38%
1-Day Range:
Value
$15.70
$16.44
1-Week Range:
Value
$15.70
$17.48
52-Week Range:
Value
$7.692
$19.93

Assembly Biosciences Inc Stock (ASMB) Company Profile

Name
Name
Assembly Biosciences Inc
Name
Phone
(833) 409-4583
Name
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Name
Employee
65
Name
Twitter
Name
Next Earnings Date
2024-12-06
Name
Latest SEC Filings
Name
ASMB's Discussions on Twitter

Compare ASMB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ASMB 15.93 99.63M 0 -61.23M 22.49M -1.63
VRTX 467.02 119.83B 10.63B -479.80M -1.35B 13.33
REGN 759.96 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 564.96 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 231.32 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.42 24.08B 3.30B -501.07M 1.03B 11.54

Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-13-21 Initiated H.C. Wainwright Neutral
Sep-02-21 Downgrade William Blair Outperform → Mkt Perform
Mar-23-21 Downgrade SVB Leerink Outperform → Mkt Perform
Nov-06-20 Downgrade Jefferies Buy → Hold
Oct-19-20 Initiated Truist Buy
Oct-16-19 Initiated Mizuho Buy
Nov-19-18 Initiated Leerink Partners Outperform
Oct-08-18 Upgrade B. Riley FBR Neutral → Buy
Aug-08-18 Initiated Robert W. Baird Outperform
Apr-13-18 Downgrade Chardan Capital Markets Buy → Neutral
Jan-05-18 Initiated B. Riley FBR, Inc. Neutral
Nov-08-17 Initiated Jefferies Buy
May-30-17 Initiated Chardan Capital Markets Buy
View All

Assembly Biosciences Inc Stock (ASMB) Latest News

pulisher
Nov 17, 2024

(ASMB) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Adjusts Stake in Assembly Biosciences Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

What is HC Wainwright's Forecast for ASMB FY2024 Earnings? - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 51.2% in October - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Analyzing Taysha Gene Therapies (NASDAQ:TSHA) & Gilead Sciences (NASDAQ:GILD) - Defense World

Nov 12, 2024
pulisher
Nov 08, 2024

Assembly Biosciences: Q3 Earnings Snapshot - CTPost

Nov 08, 2024
pulisher
Nov 07, 2024

Assembly Biosciences initiates at-the-market equity program - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Assembly Biosciences Inc (ASMB) Reports Q3 2024 Revenue of $6.8M, GAAP EPS Loss of $1.51, Misses Estimates - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release

Nov 07, 2024
pulisher
Nov 07, 2024

Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

When (ASMB) Moves Investors should Listen - Stock Traders Daily

Nov 06, 2024
pulisher
Oct 30, 2024

Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences - Genetic Engineering & Biotechnology News

Oct 30, 2024
pulisher
Oct 30, 2024

Short Interest in Assembly Biosciences, Inc. (NASDAQ:ASMB) Declines By 7.9% - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat

Oct 30, 2024
pulisher
Oct 26, 2024

(ASMB) Investment Analysis and Advice - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 24, 2024

Microbiome Manufacturing Market Poised for Robust Growth at 15.4% CAGR by 2031 - WhaTech

Oct 24, 2024
pulisher
Oct 22, 2024

Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat

Oct 22, 2024
pulisher
Oct 13, 2024

Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - MarketBeat

Oct 13, 2024
pulisher
Oct 12, 2024

Assembly Biosciences, Inc.'s (NASDAQ:ASMB) market cap surged US$16m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St

Oct 12, 2024
pulisher
Oct 09, 2024

Assembly Biosciences sees major stock purchase by investor Alexander Schornstein By Investing.com - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

Alexander Schornstein Purchases 10,000 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Stock - MarketBeat

Oct 09, 2024
pulisher
Oct 05, 2024

Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Oct 05, 2024
pulisher
Oct 05, 2024

Assembly Biosciences CEO sells shares worth $2,917 to cover taxes By Investing.com - Investing.com South Africa

Oct 05, 2024
pulisher
Oct 05, 2024

Assembly Biosciences CEO sells shares worth $2,917 to cover taxes - Investing.com India

Oct 05, 2024
pulisher
Oct 05, 2024

How To Trade (ASMB) - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 04, 2024

Assembly Biosciences executive sells shares worth $2,325 By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 04, 2024

Assembly Biosciences executive sells shares worth $2,325 - Investing.com India

Oct 04, 2024
pulisher
Oct 02, 2024

Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance

Oct 02, 2024
pulisher
Sep 28, 2024

Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Growth in Short Interest - MarketBeat

Sep 28, 2024
pulisher
Sep 26, 2024

Armistice Capital LLC Makes New Investment in Assembly Biosciences, Inc. (NASDAQ:ASMB) - MarketBeat

Sep 26, 2024
pulisher
Sep 24, 2024

Investment Analysts’ Updated EPS Estimates for September 24th (AB, AG, AIOT, AIR, AMWL, ASMB, BAG, BDTX, BHVN, BIIB) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Assembly Biosciences (NASDAQ:ASMB) Rating Reiterated by HC Wainwright - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

(ASMB) Trading Signals - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 23, 2024

Assembly Biosciences advances genital herpes treatment study - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants - AOL

Sep 23, 2024
pulisher
Sep 23, 2024

Tonight | The Assembly on ABC and ABC iview S1E6 - TV Central

Sep 23, 2024
pulisher
Sep 23, 2024

Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting - EIN News

Sep 23, 2024
pulisher
Sep 23, 2024

Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 - StockTitan

Sep 23, 2024
pulisher
Sep 22, 2024

The Assembly: Sept 24 - TV Tonight

Sep 22, 2024
pulisher
Sep 20, 2024

Jefferies sees upside in Assembly Biosciences stock ahead of key Phase IA data - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Schlumberger Limited (NYSE:SLB) Holdings Lifted by Richardson Financial Services Inc. - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Assembly Biosciences (NASDAQ:ASMB) Upgraded to Buy by Jefferies Financial Group - MarketBeat

Sep 20, 2024
pulisher
Sep 17, 2024

Assembly Coffee closing after two years in Ballard - My Ballard

Sep 17, 2024

Assembly Biosciences Inc Stock (ASMB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$358.51
price down icon 1.26%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):